The U.S. Food and Drug Administration has issued a report on how the agency communicates the benefits and risks of medical products to health care providers and patients, especially underrepresented populations, including racial subgroups.
FDA has opened a docket to seek public comment on the report's findings and FDA's communication plans going forward.
Please submit electronic or written comments by September 9, 2013.
For more information click the language links below:
In English , 中文 (Chinese), Français (French), Español (Spanish), Tagalog (Tagalog), and Việt (Vietnamese)
FDA has opened a docket to seek public comment on the report's findings and FDA's communication plans going forward.
Please submit electronic or written comments by September 9, 2013.
For more information click the language links below:
In English , 中文 (Chinese), Français (French), Español (Spanish), Tagalog (Tagalog), and Việt (Vietnamese)
